Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
FARMINGDALE, NY, Oct. 30, 2023 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ) (“Enzo” or “the Company”), a leading life sciences company, announced today that Steven J. Pully has been appointed...
-
Fort Collins, Colorado, Oct. 27, 2023 (GLOBE NEWSWIRE) -- According to DataHorizzon Research, the Nuclear Medicine Market size was valued at USD 8.1 Billion in 2022 and is expected to reach USD 46.3...
-
CALGARY, Alberta, Sept. 25, 2023 (GLOBE NEWSWIRE) -- Eguana Technologies Inc. (“Eguana”) (TSX.V: EGT) (OTCQB: EGTYF), a developer and manufacturer of high-performance energy storage systems and...
-
LONDON, Sept. 18, 2023 (GLOBE NEWSWIRE) -- As per The Business Research Company’s Radiotherapy Devices Global Market Report 2023, the global radiotherapy devices market is poised for substantial...
-
New York, Sept. 15, 2023 (GLOBE NEWSWIRE) -- According to a recent report by Market.us, the Global Nuclear Medicine Market size is expected to be worth around USD 25 Million by 2032 from USD 7.0...
-
Dubai, UAE, Sept. 11, 2023 (GLOBE NEWSWIRE) -- According to Extrapolate's recent report, the Global Radiopharmaceuticals Market revenue is expected to surpass USD 8.8 billion by 2032 from around USD...
-
FARMINGDALE, NY, Sept. 06, 2023 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) announced today that Hamid Erfanian, Chief Executive Officer (CEO), will be resigning his seat on the Board of...
-
HARRISBURG, PA, Sept. 05, 2023 (GLOBE NEWSWIRE) -- Pace-O-Matic, Inc. (POM) released the following statement after United States District Judge Jennifer Wilson issued an order removing confidential...
-
Wilmington,Delaware, Aug. 28, 2023 (GLOBE NEWSWIRE) -- Global Radiotherapy Patient Positioning Accessories Market is valued at US$ 598.1 million in 2022 and is expected to grow at a significant CAGR...
-
Adjusted EBITDA significantly rebounded by 137%, and Adjusted EBITDA Margin doubled, in Q2 2023 compared to Q1 2023; Company expects further improvement to Adjusted EBITDA and Adjusted EBITDA Margin...